Regencell Bioscience Holdings Limited - stock earnings
RGC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q2 | -1.9 million USD | ? USD |
| 2022Q1 | -1.9 million USD | ? USD |
| 2021Q4 | -1.8 million USD | ? USD |
| 2021Q3 | -1.8 million USD | ? USD |
RGC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -7.4 million USD | ? USD |
| 2021 | -1.3 million USD | ? USD |
| 2020 | -812371 USD | ? USD |
| 2019 | -390990 USD | ? USD |
RGC
Price: 14.48USD
52 week price:
Dividend Yield: 3.83%
Payout Ratio Range:
Earnings Per Share: 1.09 USD
P/E Ratio: 26.12
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Volume: 700
Ebitda: 521.8 millionMarket Capitalization: 290.2 million
Average Dividend Frequency: 4